Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Oct;32(10):1565–1570. doi: 10.1128/aac.32.10.1565

Human granulocyte activity against moxalactam-induced filamentous forms of Pseudomonas aeruginosa.

M C Hammer 1, A L Baltch 1, R P Smith 1, J V Conroy 1, M Bishop 1, P Michelsen 1, L Hill 1
PMCID: PMC175920  PMID: 2461161

Abstract

The purpose of this investigation was to study the kinetics of human granulocyte (polymorphonuclear leukocyte) phagocytosis and bactericidal activity against beta-lactam antibiotic (moxalactam)-induced filamentous bacterial forms of Pseudomonas aeruginosa. Ultrastructural observations of rod and filamentous forms of P. aeruginosa and their interaction with polymorphonuclear leukocytes are presented. Growth of P. aeruginosa 1348A in the presence of 4 micrograms of moxalactam per ml (one-fourth the MIC) resulted in filamentous forms. Phagocytosis of 75Se-radiolabeled filaments was more efficient than that of rods during the first 20 min of the assay; subsequently, phagocytosis of both forms was equal. The polymorphonuclear leukocyte bactericidal activities against both forms, which were standardized to equal bacterial particle and viable-cell counts, were equivalent. Considering the greater size and mass of filaments compared with those of rods, we concluded that filaments are more susceptible to both phagocytosis and killing than are bacillary forms.

Full text

PDF
1565

Images in this article

1568Image
on p.1568
1568Image
on p.1568
1569Image
on p.1569

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeMatteo C. S., Hammer M. C., Baltch A. L., Smith R. P., Sutphen N. T., Michelsen P. B. Susceptibility of Pseudomonas aeruginosa to serum bactericidal activity. A comparison of three methods with clinical correlations. J Lab Clin Med. 1981 Oct;98(4):511–518. [PubMed] [Google Scholar]
  2. Fisher M. W., Devlin H. B., Gnabasik F. J. New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J Bacteriol. 1969 May;98(2):835–836. doi: 10.1128/jb.98.2.835-836.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Govan J. R., Gillies R. R. Further studies in the pyocine typing of Pseudomonas pyocyanea. J Med Microbiol. 1969 Feb;2(1):17–25. doi: 10.1099/00222615-2-1-17. [DOI] [PubMed] [Google Scholar]
  4. Hammer M. C., Baltch A. L., Sutphen N. T., Smith R. P., Conroy J. V. Pseudomonas aeruginosa: quantitation of maximum phagocytic and bactericidal capabilities of normal human granulocytes. J Lab Clin Med. 1981 Dec;98(6):938–948. [PubMed] [Google Scholar]
  5. Lorian V., Atkinson B. A. Effect of serum and blood on Enterobacteriaceae grown in the presence of subminimal inhibitory concentrations of ampicillin and mecillinam. Rev Infect Dis. 1979 Sep-Oct;1(5):797–806. doi: 10.1093/clinids/1.5.797. [DOI] [PubMed] [Google Scholar]
  6. Lorian V., Atkinson B. Bactericidal effect of polymorphonuclear neutrophils on antibiotic-induced filaments of gram-negative bacilli. J Infect Dis. 1984 May;149(5):719–727. doi: 10.1093/infdis/149.5.719. [DOI] [PubMed] [Google Scholar]
  7. Lorian V., Atkinson B., Kim Y. Phagocytosis of filaments of Escherichia coli produced with mezlocillin. J Antimicrob Chemother. 1983 May;11 (Suppl 100):71–78. doi: 10.1093/jac/11.suppl_c.71. [DOI] [PubMed] [Google Scholar]
  8. Milatovic D. Antibiotics and phagocytosis. Eur J Clin Microbiol. 1983 Oct;2(5):414–425. doi: 10.1007/BF02013898. [DOI] [PubMed] [Google Scholar]
  9. Nishida M., Mine Y., Nonoyama S., Yokota Y. Effect of antibiotics on the phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes. Chemotherapy. 1976;22(3-4):203–210. doi: 10.1159/000221927. [DOI] [PubMed] [Google Scholar]
  10. Olling S. Sensitivity of gram-negative bacilli to the serum bactericidal activity: a marker of the host-parasite relationship in acute and persisting infections. Scand J Infect Dis Suppl. 1977;(10):1–40. doi: 10.3109/inf.1977.9.suppl-10.01. [DOI] [PubMed] [Google Scholar]
  11. Root R. K., Rosenthal A. S., Balestra D. J. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes. J Clin Invest. 1972 Mar;51(3):649–665. doi: 10.1172/JCI106854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. VON BERTALANFFY L. Quantitative laws in metabolism and growth. Q Rev Biol. 1957 Sep;32(3):217–231. doi: 10.1086/401873. [DOI] [PubMed] [Google Scholar]
  13. Young L. S., Armstrong D. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis. 1972 Sep;126(3):257–276. doi: 10.1093/infdis/126.3.257. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES